Trends in the prescription of secondary prevention medication at hospital discharge after myocardial infarction

25 August 2018 (00:00 - 00:00)

Organised by:

Sign in to view the resources

Sign in for access options

About the speaker

Ms Fabienne Foster-Witassek

UZH - Epidemiology, Biostatistics and Prevention Institute, Zurich (Switzerland)

32 More presentations in this session

Presentation thumbnail

Impact of comorbidities on major adverse events in atrial fibrillation: 3 years follow-up of the EORP-AF general pilot registry

Associate Professor M. Proietti (Milan, IT)

Abstract Slides

Presentation thumbnail

ABC-death risk score predicts mortality better than CHA2DS2-VASc score in a contemporary population of hospitalised patients with atrial fibrillation

Professor G. Giannakoulas (Thessaloniki, GR)

Abstract Slides

Presentation thumbnail

Intima-Media thickness to better risk-stratify patients with premature coronary artery disease: an analysis from the AFUI registry.

Associate Professor M. Zeitouni (Paris, FR)

Abstract Slides

Presentation thumbnail

Prognostic value of elevated electromagnetic QRS-fragmentation index on 5-year outcome in patients with acute myocardial infarction undergoing cardiac magnet field imaging

Mr O. Mohammad (Ludwigshafen, DE)

Presentation thumbnail

The prognostic importance of pulmonary pressure increase in early cardiovascular diseases

Doctor P. Giovanardi (Modena, IT)

Abstract Slides

Access the full session

Session thumbnail

Poster Session 7 - Secondary prevention

The Event

ESC Congress 2018

25 August - 29 August 2018

You may be interested in

Congress Presentation

Making personalised prevention everyone's business

Webinar

Personalised secondary prevention post-ACS: the role of biomarkers

Webinar

Aspirin treatment for mitigating thrombotic risk across the cardiovascular risk continuum

ESC 365 is supported by

novartis

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources